Game Changing Week in Diabetes: Oral GLP- 1 Agonist and New Pro CGM

Boy! What an exciting week it has been in the diabetes realm! Here in the states, FDA approved oral semaglutide (Rybelsus), first ever oral GLP-1 agonist. How exciting for those living with type 2 diabetes who have avoided GLP-1 agonist because it is an injection as they have an oral option. This is a game changer. It will be available in 7 mg and 14 mg. Costs are not available at this time however there will be a savings card program. Rybelsus will be available in fourth quarter 2019.

https://www.novonordisk-us.com/media/news-releases.html?122973

In Europe, Medtronic received approval for a new disposable, factory calibrated professional CGM (Envision Pro). This eliminates the need for finger stick calibration. Envision Pro will be available in Europe and Middle East this fall. I am counting the days until we get FDA approval for this professional CGM here in the states.

http://newsroom.medtronic.com/news-releases/news-release-details/medtronic-introduces-envisiontm-pro-continuous-glucose?utm_source=Closer+Look+Subscribers+2018&utm_campaign=32e4700141-2019-09-17_%28HTML_LINKS%2909_17_2019&utm_medium=email&utm_term=0_c55d924bf1-32e4700141-412262441

Please share your thoughts and subscribe to receive my blogs.

#oral #semaglutide #EnvisionPro

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram ReecesPiecesDI.